Search results
Results from the WOW.Com Content Network
Over its history, PerkinElmer has been split in two twice. In 1999, PerkinElmer merged with EG&G, with the ongoing Analytical Instruments Division of Perkin-Elmer keeping that name, while the life sciences division of the company became the separate PE Corporation. In 2022, a split of PerkinElmer resulted in one part, comprising applied, food ...
In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name.
As the former Perkin-Elmer, Applera had a history dating back to 1931. But more precisely, its history dates from 1999, when Perkin-Elmer effectively split in half, and sold off its more traditional half of the business to EG&G Inc. As part of the deal, it also sold the Perkin-Elmer name, because that most properly associated with that ...
There's no foolproof way to know the future for PerkinElmer (NYSE: PKI ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your ...
Perkin-Elmer acquired Horizon Discovery for $383 million (£296 million) in November 2020. [4] Due to Perkin-Elmer split, since May 2023 Horizon Discovery is now part of Revvity, Inc. [ 5 ] Gene Editing
PerkinElmer (NYS: PKI) is expected to report Q2 earnings on Aug. 2. Here's what Wall Street wants to see. The 10-second takeawayComparing the upcoming quarter with the prior-year quarter, average ...
[15] [16] Noubar Afeyan, Ph.D., had been the founder, Chairman, and CEO of PerSeptive, and with the Perkin-Elmer successor company he set up the later tracking stock for Celera. In 1998, Perkin-Elmer formed the PE Biosystems division, by consolidating Applied Biosystems, PerSeptive Biosystems, Tropix and PE Informatics. [14]
For the last fully reported fiscal quarter, PerkinElmer's year-over-year revenue grew 8.3%, and its AR grew 11.2%. That looks OK. End-of-quarter DSO increased 2.7% over the prior-year quarter.